WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

UTHR past earnings growth

How has UTHR's earnings growth performed historically?
Company
31.66%
Industry
52.67%
Market
71.87%
UTHR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
UTHR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
UTHR's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

UTHR past revenue growth

How has UTHR's revenue growth performed historically?
Company
20.2%
Industry
145.73%
Market
17.2%
UTHR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
UTHR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
UTHR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

UTHR earnings and revenue history

Current Revenue
$2.3B
Current Earnings
$984.8M
Current Profit Margin
42.3%
UTHR's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

UTHR Return on Equity

Current Company
17.7%
Current Industry
-63.5%
Current Market
188%
UTHR's Return on Equity (17.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when UTHR announces earnings.

UTHR Return on Assets

Current Company
14.5%
Current Industry
2.9%
UTHR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

UTHR Return on Capital Employed

Current Company
20.96%
Current Industry
19.5%
UTHR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

UTHR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
UTHR$2.33B$1.39B$984.80M+7.41%+9.22%
INCY$3.70B$919.43M$597.60M+14.45%+38.71%
SRPT$1.24B-$461.21M-$535.98M+32.80%N/A
TECH$1.14B$372.91M$224.16M+10.93%+17.11%
ROIV$123.24M$4.58B$4.47B+41.90%N/A
View Top Biotech Stocks

UTHR earnings dates

Next earnings date
May 1, 2024

United Therapeutics Earnings & Revenue FAQ

What were UTHR's earnings last quarter?

On Invalid Date, United Therapeutics (NASDAQ: UTHR) reported Q4 2023 earnings per share (EPS) of $4.60, up 61.97% year over year. Total United Therapeutics earnings for the quarter were $217.10 million. In the same quarter last year, United Therapeutics's earnings per share (EPS) was $2.84.

If you're new to stock investing, here's how to buy United Therapeutics stock.

What was UTHR's earnings growth in the past year?

As of Q2 2024, United Therapeutics's earnings has grown 31.66% year over year. This is 21.01 percentage points lower than the US Biotechnology industry earnings growth rate of 52.67%. United Therapeutics's earnings in the past year totalled $984.80 million.

What is UTHR's earnings date?

United Therapeutics's earnings date is Invalid Date. Add UTHR to your watchlist to be reminded of UTHR's next earnings announcement.

What was UTHR's revenue last quarter?

On Invalid Date, United Therapeutics (NASDAQ: UTHR) reported Q4 2023 revenue of $614.70 million up 25.07% year over year. In the same quarter last year, United Therapeutics's revenue was $491.50 million.

What was UTHR's revenue growth in the past year?

As of Q2 2024, United Therapeutics's revenue has grown 20.2% year over year. This is 125.53 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. United Therapeutics's revenue in the past year totalled $2.33 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.